Project Grant R21OD037663
Award Date
5/1/25
Completion Date
4/30/27
Dollars Obligated
$259K
Funding Federal Agency
Office of the Director
Awarding Federal Agency
Aggregate Financial Assistance Data
Federal Grant Program
93.351
Assistance Type
Project Grant
Place of Performance
Ann Arbor, MI 48109, USA
Similar Awards
This $102,794 federal Project Grant was awarded by the National Institute on Aging (CFDA 93.866 - Aging Research) to Harvard College President & Fellows Of (Harvard T.H. Chan School of Public Health) on June 7, 2024 to investigate the role of RNA splicing regulation in lipid metabolism and longevity in C. elegans. The key objectives of this research project are to: 1) Use CRISPR/Cas9 to assess the tissue-specific effects of the REPO-1 protein on alternative splicing, lipid accumulation,...
This federal Project Grant award of $623,874.00, awarded on December 15, 2024 by the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837), supports research to uncover novel regulatory pathways and functions of the telomerase RNA component (TERC) in the hematopoietic system. The primary awardee, The Washington University in St. Louis, will utilize in vitro and in vivo approaches, including human pluripotent stem cell differentiation...
This $578,254 federal Project Grant award from the National Institutes of Health (NIH) Biomedical Research and Research Training Program (CFDA 93.859) supports research investigating the role of mitochondrial metabolism in regulating the differences in developmental rates observed across mammalian species. The research aims to leverage an in vitro system that replicates the accelerated development timelines of mouse embryos compared to human embryos, with a focus on uncovering the mechanisms...
The National Institute of General Medical Sciences (NIGMS) awarded a $1,268,697 project grant under the Biomedical Research and Research Training program (CFDA 93.859) to Case Western Reserve University to investigate the roles of the POT1-TPP1 protein complex in telomere maintenance. The key objectives of this 4-year project (July 2024 to April 2028) are to: Further examine the intricate details of telomerase-mediated extension of telomere DNA and identify how changes in nucleotide pools affect...
This Project Grant award from the National Center for Advancing Translational Sciences (CFDA 93.350) provides $2,149,781 to Rejuvenation Technologies Inc. (RTI) to develop advanced tools and methods for translating their intravenously-infused RNA lipid nanoparticle (LNP) therapeutics into the clinic. Specifically, RTI will undertake four objectives: 1) developing high-sensitivity analytical capabilities for their drug products, 2) evaluating biodistribution and cell-type specificity, 3)...
The University of Pittsburgh was awarded a $750,345 Project Grant from the National Heart, Lung, and Blood Institute (CFDA 93.837 Cardiovascular Diseases Research) to investigate the role of telomerase reverse transcriptase (TERT) in the onset and progression of calcific aortic valve disease. The research aims to elucidate the epigenetic and transcriptional changes driven by TERT that facilitate the osteogenic reprogramming of aortic valve interstitial cells, leading to calcification. The...
This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) provides $649,679 to the Regents of the University of Minnesota to conduct research on mechanisms of cellular aging and longevity. The project aims to study a population of mouse T cells that can be iteratively boosted and passaged among young mice for over 11 years, retaining functionality without uncontrolled proliferation. The specific objectives are to reevaluate the Hayflick limit, assess mutational...
This Project Grant award of $404,792 from the National Institute of General Medical Sciences (NIGMS) Biomedical Research and Research Training Program (CFDA 93.859) supports research at Yale University to investigate the mechanisms regulating telomere length, protection, and replication. The key products or services to be delivered under this award include: Using biochemical, structural, cellular, and genetic approaches to explore how a phospho-dephospho switch on the human POT1 protein...
This federal Project Grant award from the National Institutes of Health's National Institute on Aging (CFDA 93.866 - Aging Research) provides $485,375 to the University of Washington to conduct research on alternative splicing and transposable element expression in aging skeletal muscle. The key products or services to be delivered under this 2-year project include: Exploring whether alternative splicing of mRNA results in quantitative differential isoform changes associated with aging,...
This Project Grant award from the National Institute of General Medical Sciences (NIGMS), under the Biomedical Research and Research Training Program (CFDA 93.859), provides $1,107,158 to the University of California, Santa Cruz (UCSC) for research on the structure and dynamics of telomeres and telomerase. The award period runs from July 1, 2024 to June 30, 2029. The funded research aims to advance the understanding of telomere and telomerase biology, which are essential for maintaining...